Search

everythinglearnresearchcommunity

for

Search:↓

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

New tools and criteria have been developed to better assess and treat pediatric lupus.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Low-dose oral minoxidil for hair loss can cause mild excessive hair growth, usually appearing within the first 3 months, but it can be managed by adjusting the dose or removing the unwanted hair, with most people not needing to stop the treatment.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Misdiagnosis led to unnecessary treatment due to a genetic mutation affecting thyroid hormone resistance.

Accurate diagnosis of SLE requires extensive testing due to its complex symptoms.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Low-Level Laser Therapy might be an effective alternative hair loss treatment for some people.

miR‑339‑5p can slow down hair follicle stem cell differentiation by targeting DLX5.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

A genetic duplication on chromosome 5 was linked to a woman's unique combination of medical conditions.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Low-level laser therapy can stimulate hair growth and increase hair density, making it a promising treatment for hair loss.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Mice with the 'lanceolate hair' mutation have abnormal hair and skin similar to human Netherton's syndrome.